Infectious agents cause around 2 million new cancer cases a year worldwide, of which 80% occur in less developed regions, according to new estimates published Online First in The Lancet Oncology. Of the 7.5 million deaths ...
May 8, 2012
0
0
(HealthDay) -- For some patients with advanced melanoma and brain metastases, ipilimumab is active, according to the results of a phase 2 study published online March 27 in The Lancet Oncology.
Mar 27, 2012
0
0
(HealthDay) -- Anal human papillomavirus (HPV) infection and precancerous lesions are common among gay and bisexual men, but most of these cases will not progress to anal cancer, a new analysis of earlier research shows.
Mar 23, 2012
0
0
(Medical Xpress) -- Fears that involuntary exposure to chemicals in food and consumer products causes cancer are not supported by evidence, and anxiety about their dangers is diverting attention from proven methods of cancer ...
Feb 28, 2012
1
0
More than three quarters (77%) of cancer patients who first present to their family doctors (GPs) with suspicious symptoms are referred to hospital after only one or two consultations, a new study has found. However, the ...
Feb 23, 2012
0
0
Women with a history of endometriosis are significantly more likely to develop three specific types of ovarian cancer (clear cell, endometrioid, and low-grade serous), according to an article published Online First in the ...
Feb 21, 2012
0
0
A study published Online First by The Lancet Oncology, and linked to The Lancet Series on cancer in pregnancy, shows that children of women exposed to chemotherapy while pregnant develop as well as children in the general ...
Feb 9, 2012
0
0
In patients with HER2-positive breast cancer, Tykerb (lapatinib) has been used both in combination with herceptin (trastuzumab) and as an alternative single-agent therapy for pre-surgery (neo-adjuvant) chemotherapy treatment. ...
Jan 16, 2012
0
0
(Medical Xpress) -- Less overall radiotherapy, delivered in fewer but higher doses, is as safe as standard, lower doses for treating prostate cancer, according to new research published in the Lancet Oncology today (Tuesday).
Dec 13, 2011
0
0
Men with locally advanced or high-risk prostate cancer who receive combined radiation and hormone therapy live longer and are less likely to die from their disease, shows clinical research led by radiation oncologists at ...
Nov 3, 2011
0
0
